34 results
Page 2 of 2
8-K
EX-3.1
8rprgv75sjkqc2
21 Sep 21
Material Modifications to Rights of Security Holders
4:38pm
8-K
EX-3.1
310jkp9
10 Sep 21
AzurRx BioPharma Announces Reverse Stock-Split
4:05pm
8-K
EX-3.1
lghyaq
25 Feb 21
AzurRx BioPharma Appoints President and CEO James Sapirstein as New Chairman of the Board of Directors
8:17am
8-K
EX-3
f9jrbu
8 Jan 21
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-3.1
0xr z00jr3owj1l
5 Aug 20
Amendments to Articles of Incorporation or Bylaws
4:25pm
8-K
EX-3
6m7ywi5z5xd e23
20 Jul 20
AzurRx BioPharma Closes $15.2 Million Private Placement and $6.9 Million Convertible Note Exchange
9:03am
8-K
EX-3.1
58t03twh
30 Dec 19
Entry into a Material Definitive Agreement
5:09pm
S-1
EX-3.1
3xmg2v z6kfxdmqs5p5a
13 Jul 16
IPO registration
12:00am
S-1
EX-3.2
wlsavl96aiyiqnc
13 Jul 16
IPO registration
12:00am
DRS
EX-3.1
8dma6s36wfzboriva6z2
8 Sep 15
Draft registration statement
12:00am
DRS
EX-3.2
6p334nn jp06ajl
8 Sep 15
Draft registration statement
12:00am
DRS
EX-3.4
u4ied85i7zcqa68e
8 Sep 15
Draft registration statement
12:00am